Chesterfield, MO, United States of America

Zhaowei Jin

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 30(Granted Patents)


Location History:

  • Cary, NC (US) (2011)
  • Chesterfield, MO (US) (2013)

Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Zhaowei Jin: Innovator in Immunogenic Composition Stability

Introduction

Zhaowei Jin is a notable inventor based in Chesterfield, MO (US). He has made significant contributions to the field of immunogenic compositions, focusing on improving their stability and preventing precipitation. With a total of 2 patents, his work addresses critical needs in the biotechnology sector.

Latest Patents

Zhaowei Jin's latest patents include formulations that stabilize and inhibit the precipitation of immunogenic compositions. These inventions aim to enhance the stability of polysaccharide-protein conjugates and protein immunogens. The formulations are designed to prevent particulate formation, such as aggregation and precipitation, during the processing, development, formulation, manufacturing, and storage of these compositions in various container means, including fermentors, bioreactors, vials, flasks, bags, syringes, rubber stoppers, and tubing.

Career Highlights

Zhaowei Jin is currently employed at Wyeth, a company known for its innovative contributions to the pharmaceutical industry. His work has been instrumental in advancing the stability of immunogenic compositions, which is crucial for their effectiveness in medical applications.

Collaborations

Zhaowei has collaborated with notable coworkers, including Lakshmi Khandke and Ronald Malone. Their combined expertise has contributed to the successful development of innovative solutions in the field of immunogenic compositions.

Conclusion

Zhaowei Jin's contributions to the stability of immunogenic compositions highlight his role as a key innovator in biotechnology. His patents reflect a commitment to addressing ongoing challenges in the field, ultimately enhancing the effectiveness of immunogenic products.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…